Biotech Heavyweight to Set up Facility in Singapore |
|||
| |||
|
Singapore has further strengthened it's position as a biomedical hub by attracting Genentech Inc. to set up its first Asia Pacific biotechnology manufacturing facility. Widely credited as pioneer and leading biotechnology corporation, Genentech was founded in 1976 by a venture capitalist - Robert A. Swanson, and a biochemist - Herbert W. Boyer. The California-based company is holding its groundbreaking ceremony for the US$140 million facility on June 28, 2007; witnessed by the key Genentech executives and Singapore’s Minister of State for Trade & Industry, Mr S Iswaran. Some of the products that have been commmercialized by Genentech after 31 years in the industry are like: Activase/Cathflo, Nutropin, Pulmozyme, Rituxan, Herceptin, TNKase, Xolair, Raptiva, Avastin, Tarceva, Lucentis. The company reported a revenue of US$9.284 Billion for the year 2006.
**********
|
